-+ 0.00%
-+ 0.00%
-+ 0.00%

Karyopharm Therapeutics Q4 Earnings Assessment

Benzinga·02/12/2026 13:58:06
Listen to the news

Karyopharm Therapeutics (NASDAQ:KPTI) reported its Q4 earnings results on Thursday, February 12, 2026 at 07:30 AM.

Here's what investors need to know about the announcement.

Earnings

Karyopharm Therapeutics missed estimated earnings by -6.19%, reporting an EPS of $-2.23 versus an estimate of $-2.1.

Revenue was up $3.54 million from the same period last year.

Analysis of Past Earnings

The company missed on EPS by $0.55 in the previous quarter, leading to a 6.92% drop share price change the next day.

Here's a look at Karyopharm Therapeutics's past performance:

Quarter Q3 2025 Q2 2025 Q1 2025 Q4 2024
EPS Estimate -3.27 -3.86 -3.09 -4.05
EPS Actual -3.82 -4.32 -2.77 -3.60
Revenue Estimate 42.37M 38.79M 35.12M 35.67M
Revenue Actual 44.00M 37.93M 30.02M 30.54M

To track all earnings releases for Karyopharm Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.